European Journal of Haematology is an international journal for communication of basic and clinical research in haematology. The journal welcomes manuscripts on molecular, cellular and clinical research on diseases of the blood, vascular and lymphatic tissue, and on basic molecular and cellular research related to normal development and function of the blood, vascular and lymphatic tissue. The journal also welcomes reviews on clinical haematology and basic research, case reports, and clinical pictures.
《欧洲血液学杂志》是一本交流血液学基础和临床研究的国际杂志。该杂志欢迎有关血液、血管和淋巴组织疾病的分子、细胞和临床研究，以及与血液、血管和淋巴组织正常发育和功能相关的基础分子和细胞研究的稿件。该杂志还欢迎对临床血液学和基础研究，病例报告和临床图片的评论。
The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: A review of the literature
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13208
Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13239
Insight into the complex pathophysiology of sickle cell anaemia and possible treatment
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13212
Molecular pathogenesis of acquired aplastic anemia
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13182
Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13223
Frequency, characteristics, and outcome of PTLD after allo‐SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13226
Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13272
The role of iron repletion in adult iron deficiency anemia and other diseases
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13345
Stratification by MYC expression has prognostic impact in MYC translocated B‐cell lymphoma—Identifies a subgroup of patients with poor outcome
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13219
Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13190
Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13316
Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B‐cell lymphoma
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13300
Targeted therapy of BRAF V600E‐mutant histiocytic sarcoma: A case report and review of the literature
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13303
Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13315
Impact of cyclosporine A concentration on acute graft‐vs‐host disease incidence after haploidentical hematopoietic cell transplantation
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13233
Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13202
Clarithromycin added to bortezomib‐cyclophosphamide‐dexamethasone impairs health‐related quality of life in multiple myeloma patients
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13175
Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single‐center experience over the past 15 years
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13235
Hematopoietic stem cell mobilization following PD‐1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13248
Transfusion strategies in patients with cirrhosis
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13342
The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13349
Risks and challenges of CML management during pregnancy: Looking for a balanced decision
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13215
Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13265
Prophylaxis of chemotherapy‐induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non‐Hodgkin lymphoma (NADIR study)
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13189
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13281
Postsurgical thrombotic microangiopathy: Case series and review of the literature
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13284
Reactivation and dynamics of cytomegalovirus and Epstein‐Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13308
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13314
A study of selected hematopoietic stem cell donors provided by an intermediate size registry
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13307
A comparative analysis of the safety profile of direct oral anticoagulants using the FDA adverse event reporting system
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13240
Daratumumab added to standard of care in patients with newly diagnosed multiple myeloma: A network meta‐analysis
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13317
Circulating extracellular vesicle‐associated CD163 and CD206 in multiple myeloma
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13371
Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13331
Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13220
The role and contribution of clonality studies in the diagnosis of lymphoproliferative disorders
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13228
Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion‐dependent patients with myelodysplastic syndromes
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13222
Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13185
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13346
Association of CD204+ macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13324
Candida colonization is associated with severe acute GVHD in adult patients undergoing single‐unit cord blood transplantation
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13341
Age at diagnosis is an important prognostic factor in Philadelphia‐negative Myeloproliferative Neoplasms
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13266
Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13364
A novel mutation in erythropoietin receptor gene (c.1308_1309insG) in an Indian patient with erythrocytosis
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13302
HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype‐phenotype correlation
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13362
Quantification of IGF‐1 receptor is useful in the differential diagnosis of essential thrombocytosis from reactive thrombocytosis
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13323
Hypercobalaminemia in myeloid and lymphoid malignancies
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13365
HIV‐1 inhibits haematopoiesis via microRNA secreted by virus‐infected CD4+ T cells
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13350
Successful autografting with enhanced circulating haemopoietic stem cell yields obtained during response to retreatment in relapsed aplastic anaemia
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13340
Outcome and characteristics of non‐measurable myeloma: A cohort study with population‐based data from the Swedish Myeloma Registry
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13351
Late polycythemic transformation in JAK2‐mutated essential thrombocythemia patients—characteristics along with a validation of 2016 WHO criteria
来源期刊：European Journal of HaematologyDOI：10.1111/ejh.13320
